Currently out of the existing stock ratings of David Windley, 210 are a BUY (62.69%), 121 are a HOLD (36.12%), 4 are a SELL (1.19%).

David Windley

Work Performance Price Targets & Ratings Chart

Analyst David Windley, currently employed at JEFFERIES, carries an average stock price target met ratio of 75.93% that have a potential upside of 15.02% achieved within 211 days.

David Windley’s has documented 593 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on CRL, Charles River Laboratories at 09-Sep-2025.

Wall Street Analyst David Windley

Analyst best performing recommendations are on NOTV (INOTIV).
The best stock recommendation documented was for NOTV (INOTIV) at 12/13/2023. The price target of $3 was fulfilled within 1 day with a profit of $0.24 (8.7%) receiving and performance score of 86.96.

Average potential price target upside

of $73.17 (23.21%) on ELV (ELEVANCE HEALTH).
of $57.32 (22.02%) on HUM (HUMANA).
of $54.38 (19.24%) on ANTM (ANTHEM).

ANTM Anthem CERN Cerner Corp CERT Certara CI Cigna Corp CNC Centene Corp CRL Charles River Laboratories CTLT Catalent HMSY HMS Holdings Corp HUM Humana ICLR ICON PLC IQV IQVIA Holdings MOH Molina Healthcare SHC Sotera Health Co STVN Stevanato Group SpA TDOC Teladoc UNH UnitedHealth Group WCG WellCare Health Plans WST West Pharmaceutical Services MDRX Allscripts Healthcare Solutions SYNH Syneos Health ELV Elevance Health NOTV Inotiv MDSO Medidata Solutions MEDP Medpace Holdings Q Quintiles Transnational CE Celanese PRAH PRA Health Sciences VEEV Veeva Systems FTRE Fortrea Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Ricky Goldwasser (MORGAN STANLEY)